Prosecution Insights
Last updated: April 19, 2026

Genetix Biotherapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18525721 COMPOUNDS FOR IMPROVED VIRAL TRANSDUCTION MONTANARI, DAVID A 1632 Non-Final OA Nov 30, 2023
17641059 TRANSDUCTION EFFICIENCY ASSAY JADHAO, SAMADHAN JAISING 1672 Final Rejection Mar 07, 2022

Managing Genetix Biotherapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month